VERACYTE, INC. Debt Securities, Held-to-maturity, Sold at Par Value
VERACYTE, INC. (VCYT) reported Debt Securities, Held-to-maturity, Sold at Par Value of $40.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:HeldtomaturitySecuritiesSoldAtPar · last filed 2026-02-26
- VERACYTE, INC. debt securities, held-to-maturity, sold at par value for the quarter ending 2023-12-31 was $0.00.
- VERACYTE, INC. debt securities, held-to-maturity, sold at par value for the quarter ending 2023-09-30 was $0.00.
- VERACYTE, INC. debt securities, held-to-maturity, sold at par value for the quarter ending 2023-06-30 was $0.00.
- VERACYTE, INC. debt securities, held-to-maturity, sold at par value for the quarter ending 2023-03-31 was $40.00M.
- VERACYTE, INC. debt securities, held-to-maturity, sold at par value for fiscal 2023 was $40.00M.
| Period end | Debt Securities, Held-to-maturity, Sold at Par Value 3 month | Debt Securities, Held-to-maturity, Sold at Par Value 6 month | Debt Securities, Held-to-maturity, Sold at Par Value 9 month | Debt Securities, Held-to-maturity, Sold at Par Value 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $40.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $40.00M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $40.00M 10-Q · filed 2023-08-09 | ||
| 2023-03-31 | $40.00M 10-Q · filed 2023-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |